€95.50
1.55% today
Xetra, Dec 04, 01:17 pm CET
ISIN
DE000A40QVM8
Symbol
1INN
Industry

innoscripta Stock price

€97.00
-32.60 25.15% 1M
+2.40 2.54% 6M
-13.00 11.82% YTD
-13.00 11.82% 1Y
-13.00 11.82% 3Y
-13.00 11.82% 5Y
-13.00 11.82% 10Y
-13.00 11.82% 20Y
Xetra, Closing price Wed, Dec 03 2025
+0.70 0.73%
ISIN
DE000A40QVM8
Symbol
1INN
Industry

Key metrics

Basic
Market capitalization
€963.0m
Enterprise Value
€931.4m
Net debt
positive
Cash
€37.5m
Shares outstanding
-
Valuation (TTM | estimate)
P/E
- | 25.8
P/S
- | 9.2
EV/Sales
- | 8.9
EV/FCF
-
P/B
20.9
Financial Health
Equity Ratio
59.8%
Return on Equity
71.4%
ROCE
-
ROIC
-
Debt/Equity
-
Financials (TTM | estimate)
Revenue
- | €104.8m
EBITDA
- | €57.7m
EBIT
- | €55.9m
Net Income
- | -
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
- | 62.0%
EBITDA
- | 53.8%
EBIT
- | 49.7%
Net Income
- | -
Free Cash Flow
-
Margin (TTM | estimate)
Gross
-
EBITDA
- | 55.0%
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
-
FCF per Share
-
Short interest
-
Employees
-
Rev per Employee
-
Show more

Is innoscripta a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,088 stocks worldwide.

innoscripta Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a innoscripta forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a innoscripta forecast:

Buy
88%
Hold
13%

Financial data from innoscripta

Income Statement P&L | Balance Sheet | Cash Flow


Quarter Annually
Mar '25
+/-
%
26 26
123% 123%
100%
- Direct Costs 0.82 0.82
8,100% 8,100%
3%
25 25
116% 116%
97%
- Selling and Administrative Expenses 5.60 5.60
24% 24%
22%
- Research and Development Expense - -
-
-
16 16
231% 231%
64%
- Depreciation and Amortization 0.08 0.08
100% 100%
0%
EBIT (Operating Income) EBIT 16 16
232% 232%
64%
Net Profit 11 11
227% 227%
43%

In millions EUR.

Don't miss a Thing! We will send you all news about innoscripta directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

innoscripta SE engages in the provision of a Software-as-a-Service (SaaS) solution for research and development (R&D) tax credits and project management. The company is headquartered in Muenchen, Bayern and currently employs 330 full-time employees. The company went IPO on 2025-05-21. The firm is specialized in cloud-based compliance software for research and development. The company operates as a funding consulting and support companies from a wide range of industries in managing and documenting their research and development (R&D) projects while securing funding. The company is engaged in development and distribution of software as a service (SaaS) solution for the research and development process, which includes project management software, software for time recording, software for employee management and the creation of data interfaces to third-party systems. The firm's platform offers solutions that support customers in identifying, validating and managing R&D projects and ensure reliable and compliant documentation for R&D tax credits.

Head office Germany
Website www.innoscripta.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today